Although we believed that MUC1 expression was not associated with the prognosis of pancreatic cancer patients, we did not deny the role of MUC1 as a potential carcinogenic factor in the development and drug resistance of pancreatic cancer. This evidence concerns the gene MUC1 and familial pancreatic carcinoma.